These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1723302)

  • 21. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
    Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction.
    Lawler CM; Bovill EG; Stump DC; Collen DJ; Mann KG; Tracy RP
    Blood; 1990 Oct; 76(7):1341-8. PubMed ID: 2119827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapid latex agglutination assay for the determination of plasma fibrinogen.
    Gargan PE; Sheehan C; Williams L; Ploplis V; Hearty U; Lowry C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):465-8. PubMed ID: 2133224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A neoantigenic determinant in the D-dimer fragment of fibrin.
    Lugovskoy EV; Kolesnikova IN; Gritsenko PG; Zolotareva EN; Gaffney P; Nieuwenhuizen W; Komisarenko SV
    Thromb Res; 2002 Aug; 107(3-4):151-6. PubMed ID: 12431482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.
    Hamano A; Tanaka S; Takeda Y; Umeda M; Sakata Y
    Clin Chim Acta; 2002 Apr; 318(1-2):25-32. PubMed ID: 11880109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
    Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
    Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of a monoclonal antibody specific for fibrinogen and fibrin of human origin.
    Sola B; Avner PR; Zilber MT; Connan F; Lévy D
    Thromb Res; 1983 Mar; 29(6):643-53. PubMed ID: 6857603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of antibody specificity in measuring cross-linked fibrin degradation products by ELISA.
    Eisenberg PR; Rylatt DB; Rusticali F; Ferrini D; Ottani F; Galvani M
    Blood Coagul Fibrinolysis; 1997 Mar; 8(2):105-13. PubMed ID: 9518041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production and characterization of a monoclonal antibody reactive with a specific neoantigenic determinant (comprising B beta 54-118) in degradation products of fibrin and of fibrinogen.
    Koppert PW; Koopman J; Haverkate F; Nieuwenhuizen W
    Blood; 1986 Aug; 68(2):437-41. PubMed ID: 3730608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits.
    Holvoet P; Stassen JM; Hashimoto Y; Spriggs D; Devos P; Collen D
    Thromb Haemost; 1989 Apr; 61(2):307-13. PubMed ID: 2749602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
    Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
    Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies with equal specificity to D-dimer and high-molecular-weight fibrin degradation products.
    Kogan AE; Mukharyamova KS; Bereznikova AV; Filatov VL; Koshkina EV; Bloshchitsyna MN; Katrukha AG
    Blood Coagul Fibrinolysis; 2016 Jul; 27(5):542-50. PubMed ID: 26656897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preparation and characterization of McAbs against the human crosslinked fibrin degradation product D-dimer].
    Qi G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Oct; 13(5):313-6. PubMed ID: 1839247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A group of monoclonal antibodies against human fibrinogen and its fragments].
    Wu XW
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):288-90. PubMed ID: 2976318
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies.
    Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL
    Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A monoclonal antibody with high affinity for a neo-antigenic site in fibrinogen degraded by polymorphonuclear leukocyte-derived elastase.
    Bos R; van Leuven CJ; Stolk J; Hiemstra PS; Dijkman JH; Nieuwenhuizen W
    Blood Coagul Fibrinolysis; 1995 May; 6(3):259-67. PubMed ID: 7544637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The detection of D-dimer in plasma by enzyme immunoassay: improved discrimination is obtained with a more specific signal antibody.
    Hart R; Bate I; Dinh D; Elms M; Bundesen P; Hillyard C; Rylatt DB
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):227-32. PubMed ID: 7519890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A monoclonal antibody with ability to distinguish between NH2-terminal fragments derived from fibrinogen and fibrin.
    Kudryk B; Rohoza A; Ahadi M; Chin J; Wiebe ME
    Mol Immunol; 1983 Nov; 20(11):1191-200. PubMed ID: 6656769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.